Search

everythinglearnresearchcommunity

for

Search:↓

The document summarizes the latest trends and advancements in cosmetic dermatology.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Cyclosporin extends hair growth in mice, but high-dose corticosteroids block this effect.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Dermal macrophages might help regrow hair.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

Exosome therapy shows promise for treating skin conditions and improving wound healing.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Skin bacteria can help wound healing by activating certain immune cells.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Four specific genes are linked to keloid formation and could be potential treatment targets.